Investigating long-term health effects in COVID-19 recoveries
A Study of the Trajectory of Overall Systemic Health Outcomes and Potential Complications in Recovered COVID-19 Patients.
This study is trying to understand the long-term health issues that people face after recovering from COVID-19 and find ways to help them feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 17000 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Capital Medical University Academic / other |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT06349720 on ClinicalTrials.gov |
What this trial studies
This study aims to clarify the incidence of functional impairments in patients who have recovered from COVID-19 and identify the factors influencing these impairments. It will build a multi-omics database to elucidate biological biomarkers and targets associated with long-term complications following Omicron infection. The research will explore the prognosis, complications, and immune characteristics of these patients, comparing the impact of different COVID-19 strains. Additionally, it seeks to develop rehabilitation strategies for patients with functional impairments and evaluate the effectiveness of various interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have recovered from COVID-19 and meet specific diagnostic criteria.
Not a fit: Patients who are pregnant, breastfeeding, or have mental disorders affecting communication may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into effective rehabilitation strategies for COVID-19 survivors, improving their long-term health outcomes.
How similar studies have performed: Other studies have shown success in exploring long-term effects of COVID-19, but this approach of integrating multi-omics data is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Meets the diagnostic criteria for confirmed cases according to the "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 10)"; 2. The participant or the authorized representative understands the entire purpose of the study, voluntarily participates in the research, and signs an informed consent form, ensuring that they can complete regular assessments at the relevant participating units and receive necessary rehabilitation treatment as required; 3. Agrees to the researcher's collection of their peripheral blood samples, saliva samples, and urine samples for the needs of the study. Exclusion Criteria: 1. Women who are pregnant or breastfeeding; 2. Individuals with mental disorders that affect normal communication; 3. Those who refuse to participate in regular assessments and rehabilitation treatments; 4. Individuals who decline to provide specimens required for the study.
Where this trial is running
Beijing, Beijing
- Beijing Institute of Respiratory Medicine — Beijing, Beijing, China (Recruiting)
Study contacts
- Study coordinator: Zhaohui Tong, Doctor
- Email: 13910930309@163.com
- Phone: +86 139 1093 0309
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.